A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis

Published:2002-12 Issue:6 Volume:47 Page:821-833
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Krueger Gerald G.,Papp Kim A.,Stough Dow B.,Loven Keith H.,Gulliver Wayne P.,Ellis Charles N.

Publisher

Elsevier BV

Subject

Dermatology

Cited by 294 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early intervention and disease modification in atopic dermatitis—the current state of the field and barriers to progress;Journal of the European Academy of Dermatology and Venereology;2023-12-08

2. Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers;Cancer Cell;2023-11

3. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis;Cochrane Database of Systematic Reviews;2023-07-12

4. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis;Cochrane Database of Systematic Reviews;2022-05-23

5. The Role of Co-Signaling Molecules in Psoriasis and Their Implications for Targeted Treatment;Frontiers in Pharmacology;2021-07-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP